Decreased expression of Apaf-1 with progression of melanoma

Pigment Cell Research

Volumn 18, Issue 1, 2005, Pages 59-62

  Mustika, Rita ^a   Budiyanto, Arief ^a   Nishigori, Chikako ^a   Ichihashi, Masamitsu ^a   Ueda, Masato ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Takarazuka Municipal Hospital   (Japan)

Author keywords

Apoptotic protease activating factor 1; Chemoresistancy; Immunohistochemistry; Melanoma; Nevus; Protein expression; Tumor progression

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; CYTOCHROME C;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; DRUG RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; PROTEIN EXPRESSION; TUMOR VOLUME;

APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; NEOPLASM METASTASIS; PROTEINS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 12844255773     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00205.x     Document Type: Article

References (14)

1. Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308.
2. Baldi, A., Santini, D., Russo, P., Catricala, C., Amantea, A., Picardo, M., Tatangelo, F., Botti, G., Dragonetti, E., Murace, R. et al. (2004). Analysis of Apaf-1 expression in human cutaneous melanoma progression. Exp Dermatol. 13, 93-97.
3. Esteller, M., and Hermann, J.G. (2002). Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 196, 1-7.
4. Fujimoto, A., Takeuchi, H., Taback, B., Hsueh, E.G., Elashoff, D., Morton, D.L., and Hoon, D.S. (2004). Allelic imbalance of 12q22-23 associated with Apaf-1 locus correlates with poor disease outcome in cutaneous melanoma. Cancer Res. 64, 2245-2250.
5. Gerhard, M.C., Schmid, R.M., and Hacker, G. (2002). Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br J Cancer. 86, 893-898.
6. Green, D.R., and Reed, J.C. (1998). Mitochondria and apoptosis. Science. 281, 1309-1312.
7. Hahn, C., Hirsch, B., Jahnke, D., Durkop, H., and Stein, H. (1999). Three new types of Apaf-1 in mammalian cells. Biochem Biophys Res Commun. 261x, 746-749.
8. Jia, L., Srinivasula, S.M., Liu, F.T., Newland, A.C., Fernandes-Alnemri, T., Alnemri, E.S., and Kelsey, S.M. (2001). Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood. 98, 414-421.
9. Liu, J.R., Opipari, A.W., Tan, L., Jiang, Y., Zhang, Y., Tang, H., and Nunez, G. (2002). Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res. 62, 924-931.
10. Macleod, K. (2000). Tumor suppressor genes. Curr Opin Genet Dev. 10, 81-93.
11. Nunez, G., Benedict, M.A., Hu, Y., and Inohara, N. (1998). Caspases: the proteases of the apoptotic pathway. Oncogene. 17, 3237-3245.
12. Soengas, M.S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J.G., Gerald, W.L., Lazebnik, Y.A. et al. (2001). Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 409, 207-211.
13. Strasser, A., O'Connor, L., and Dixit, V.M. (2000). Apoptosis signaling. Annu Rev Biochem. 69, 217-245.
14. Teitz, T., Wei, T., Liu, D., Valentine, V., Valentine, M., Grenet, J., Lahti, J.M., and Kidd, V.J. (2002). Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Oncogene. 21, 1848-1858.